| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | adrenomedullin binding protein ELISA Kit; age related maculopathy susceptibility 1 ELISA Kit; AHUS 1 ELISA Kit; AHUS1 ELISA Kit; AMBP 1 ELISA Kit; AMBP1 ELISA Kit; ARMD 4 ELISA Kit; ARMD4 ELISA Kit; ARMS 1 ELISA Kit; ARMS1 ELISA Kit; beta 1 H globulin ELISA Kit; beta 1H ELISA Kit; beta1H ELISA Kit; CFAH_HUMAN ELISA Kit; CFH ELISA Kit; CFHL 3 ELISA Kit; CFHL3 ELISA Kit; Complement factor H ELISA Kit; complement factor H; isoform b ELISA Kit; Factor H ELISA Kit; factor H like 1 ELISA Kit; FH ELISA Kit; FHL 1 ELISA Kit; FHL1 ELISA Kit; H factor 1 (complement) ELISA Kit; H factor 1 ELISA Kit; H factor 2 (complement) ELISA Kit; HF 1 ELISA Kit; HF 2 ELISA Kit; HF ELISA Kit; HF1 ELISA Kit; HF2 ELISA Kit; HUS ELISA Kit; MGC88246 ELISA Kit |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Detection Wavelength | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | serum, plasma, tissue homogenates |
| Sensitivity | |
| Species | |
| Target | |
| UniProt # |
Background
complement factor H (CFH) is a biological molecule commonly studied in immunology research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.
UniProt: P08603
Biological context
Researchers often monitor complement factor H in serum, plasma, and tissue homogenates to better understand themes such as innate and adaptive immune responses, cytokine signaling networks, and host–pathogen interactions. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in complement factor H may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, cytokines, chemokines, acute-phase proteins, and immune-cell activation markers) and by keeping pre-analytical variables consistent across groups.
Nomenclature
In publications and databases, complement factor H may also appear under names such as adrenomedullin binding protein and age related maculopathy susceptibility 1. When comparing studies, confirm that the reported analyte refers to the same molecule and species context.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that complement factor H participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Intercellular mitochondrial transfer as a means of revitalizing injured glomerular endothelial cells
LX Tang,World Journal of Stem Cells,2022
Complement Factor H and Related Proteins as Markers of Cardiovascular Risk in Pediatric Chronic Kidney Disease
Wei-Ting Liao,Pharmaceuticals,2022
Relationship between advanced glycated end products and maternal cognition in gestational diabetes: a case control study
AK Sharma,The Journal of Maternal-Fetal & Neonatal Medicine,2021
iTRAQ-based quantitative proteomic analysis reveals potential early diagnostic markers in serum of acute cellular rejection after liver transplantation
Jiang Q, et al,Transplant immunology,2018
Identification of Differentially Expressed Proteins in the Serum of Colorectal Cancer Patients Using 2D-DIGE Proteomics Analysis
Lay Cheng Lim,.et al,Pathology & Oncology Research,2016
Gelsolin and Ceruloplasmin as Potential Predictive Biomarkers for Cervical Cancer by 2D-DIGE Proteomics Analysis
Lokamani I et al,Pathol Oncol Res,2013
Serum proteomics of methamphetamine addicts and up-regulation of complement factor H related to methamphetamine addiction
/,Neuroscience Letters,2012